Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Gln-AMS(TFA) inhibits glutaminyl-tRNA synthetase (GlnRS) with a Ki of 1.32 μM. Gln-AMS (TFA) is a type Ia aminoacyl-tRNA synthetase (AARS) inhibitor.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | $ 486.00 | |
10 mg | Inquiry | $ 750.00 | |
25 mg | Inquiry | $ 1,542.00 | |
50 mg | Inquiry | $ 2,421.00 | |
100 mg | Inquiry | $ 3,476.00 | |
200 mg | Inquiry | Inquiry | |
500 mg | Inquiry | Inquiry | |
1 mL * 10 mM (in DMSO) | Inquiry | $ 629.00 |
Description | Gln-AMS(TFA) inhibits glutaminyl-tRNA synthetase (GlnRS) with a Ki of 1.32 μM. Gln-AMS (TFA) is a type Ia aminoacyl-tRNA synthetase (AARS) inhibitor. |
Targets&IC50 | GlnRS:ki: 1.32 µM |
In vitro | Gln-AMS (TFA) is a type Ia aminoacyl-tRNA synthetase (AARS) inhibitor. |
Synonyms | Gln-AMS TFA |
Molecular Weight | 588.47 |
Formula | C17H23F3N8O10S |
CAS No. | T11403L |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 100 mg/mL (169.93 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Gln-AMS TFA (209543-57-7 free base) T11403L Others 209543-57-7 free base 209543-57-7 GlnAMS TFA (209543577 free base) Gln-AMS TFA Gln AMS TFA (209543 57 7 free base) inhibitor inhibit